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Abstract: The influence of maternal macronutrient balance and dietary glycemic index (GI) on
neonatal body composition has received little study. We hypothesized that the overall quantity and
quality of macronutrients, particularly carbohydrate, in the maternal diet could have trimester-specific
effects on neonatal growth and body composition in women at risk of gestational diabetes. Maternal
diet was assessed using 3-day food records in mid (n = 96) and late (n = 88) pregnancy as part of the
GI Baby 3 study. Neonatal body composition was assessed by air-displacement plethysmography
within 48 h of birth, adjusted for length, and expressed as fat mass index (FMI) and fat-free mass
index (FFMI). In mid pregnancy, higher maternal intake of carbohydrate energy was negatively
correlated with infant FFMI (p = 0.037). In late pregnancy, higher dietary GI was associated with
lower FFMI (p = 0.010) and higher carbohydrate energy predicted lower FMI (p = 0.034). Higher fat
intake (%E) and saturated fat, but not protein, also predicted neonatal body composition (higher
FFMI in mid pregnancy and higher FMI in late pregnancy). Depending on pregnancy stage, a high
carbohydrate-low fat diet, particularly from high glycemic sources, may reduce neonatal indices of
both lean mass and adiposity.
Keywords: maternal; pregnancy; dietary intake; nutrition; macronutrient; gestational diabetes
mellitus; Pea Pod; neonates; body composition
1. Introduction
Prenatal nutrition plays a critical role in defining offspring health [1,2]. Optimal fetal growth
depends on adequate maternal nutrient supply at each specific stage of fetal development. Studies
from the Dutch famine showed that exposure to famine in early but not late pregnancy was associated
with increased obesity risk and markers of the metabolic syndrome in adult life, suggesting that
prenatal undernutrition has long-term effects that depend on its timing [3,4]. It is conceivable that
dietary extremes at the time of conception (but not later) have more effect on tissue differentiation and
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proliferation while diet in later pregnancy may influence fetal adiposity [5,6]. Birth weight has long
been recognized as a determinant for disease in later life [7,8]. However, size at birth is influenced by
multiple factors, including genetic inheritance, maternal constraints [9], maternal metabolism [10,11]
and smoking [12], making birth weight a poor surrogate for disease risk in adult life. Recent evidence
indicates that neonatal body composition is a more sensitive marker of intrauterine environment than
birth weight and a better predictor of long-term health outcomes [13,14].
Despite the strong link between maternal diet and offspring health, the effect of macronutrient
distribution on neonatal growth and body composition has not been explored. One of the main
challenges in determining the optimal maternal diet lies in the fact that diets are a complex combination
of foods and focusing on single nutrients fails to account for the interactions between nutrients [15].
Additionally, much of the evidence highlighting the importance of prenatal nutrition in influencing fetal
growth comes from interventional studies of dietary supplementation in undernourished groups [2].
Compelling evidence in animal models suggests that, rather than macronutrients acting individually,
their interactive effects (balance) influence long-term health [16,17]. In humans, maternal dietary
balance has been shown to dictate fetal adiposity and fat distribution, assessed by ultrasound at
36 weeks of gestation [18]. Furthermore, as maternal diet can induce epigenetic changes [5] and affect
long-term body composition [19], understanding the interaction between maternal nutrition balance
and offspring body composition could provide insight on long-term disease susceptibility.
The aim of this study was therefore to explore the associations between maternal macronutrient
balance, carbohydrate quality (glycemic index, GI) and neonatal body composition, in women at risk
of gestational diabetes mellitus (GDM). Maternal dietary intake was assessed at two separate time
points (mid and late pregnancy). We hypothesized that nutrient supply would have different effects
on neonatal body composition, depending on the timing of pregnancy. We used data derived from the
GI Baby 3 study, a two-arm parallel randomized controlled trial assessing the effects of a low glycemic
index (GI) compared to a high fiber diet in pregnancy on perinatal outcomes [20].
2. Materials and Methods
2.1. Sample
This ecologic study is a secondary analysis of the GI Baby 3 study, a two-arm randomized
controlled trial, assessing the effects of a low GI diet compared to a conventional high fibre diet
during pregnancy on perinatal outcomes (n = 139) [20]. Women with singleton pregnancy who were
at risk of developing GDM were recruited at 14–20 weeks gestation from the antenatal clinic at the
Royal Prince Alfred Hospital, Sydney, Australia. Women were eligible if they had at least one of
the following risk factors for GDM: pre-pregnancy BMI ě30 kg/m2, age ě35 years, polycystic ovary
syndrome, previous history of GDM, previous history of newborn >4000 g, family history of type 2
diabetes (first degree relatives), belonging to an ethnic group with high prevalence of GDM (Aboriginal,
Torres Strait Islander, Polynesian, Middle Eastern, Indian, Asian). The GI Baby 3 study focused on
women clinically identified as being at risk of developing GDM as this group is more likely to show
elevated blood glucose concentrations during pregnancy. Exclusion criteria were special dietary
requirements (gluten-intolerant, celiac disease), pre-existing diabetes, unable to understand English or
to comply with scheduled visits during pregnancy (5 visits). A total of 139 women joined the study
and 125 completed the study (34–36 weeks of gestation). The GI Baby 3 study was conducted in
accordance with the ethical standards of the Human Research Ethics Committee of the Sydney South
West Area Health Service (Royal Prince Alfred Hospital zone; reference no. HREC/10/RPAH/453).
All participants gave written informed consent.
2.2. Data Collection
Maternal demographics were collected at the first visit (week 14–20 of gestation). Women
underwent an oral glucose tolerance test (OGTT) at study entry (<20 weeks gestation). In women
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free from GDM, a second OGTT was undertaken at 26–28 weeks of gestation. GDM diagnosis was
based on the 1998 Australasian Diabetes in Pregnancy Society criteria [21]. Maternal insulin sensitivity
index (ISI) was calculated according to the Matsuda and deFronzo formula [22]. Gestational weight
gain (GWG) was computed as the difference between measured weight at 34–36 weeks gestation
and self-reported pre-pregnancy weight and categorized according to the 2009 Institute of Medicine
(IOM) recommendations [23]. Information on perinatal outcomes was obtained from medical records.
Maternal dietary intake was assessed using 3-day food records (two week-days and one weekend day)
at week 14–20 of gestation, referred to as mid pregnancy (diet prior to the dietary intervention), and
at week 34–36 of gestation, referred as late pregnancy (diet post dietary intervention). Written and
verbal instructions on how to complete the 3-day food records was provided by the research dietitian.
Participants were asked to weigh or measure everything they consumed over the three days using
kitchen scales or household implements (e.g., metric measuring cups or spoons), and to note product
brand names, cooking methods, and provide recipes where relevant. Completed food diaries were
reviewed by the dietitian in consultation with the subjects, and uncertainties with regards to portion
size were clarified using visual aids such as measuring cups. All women were advised to increase their
intake of fibre-rich foods including wholegrains, vegetables and fruit. Women in the low GI group
were specifically encouraged to consume the low GI versions of these foods. Dietary data was analyzed
using the computer program “Food Works Professional” (FoodWorks 7 Professional; Xyris Software,
Brisbane, QLD, Australia) based on the Australian food composition database AUSTNUT2007. Dietary
GI values were assigned to carbohydrate food items using published sources [24] and the University
of Sydney GI Research Service database. Validity of the 3-day food records was assessed using the
Goldberg cut-off [25] where energy intake (EI) was obtained from the food records and the basal
metabolic rate (BMR) was estimated using the Schofield equation [26]. Physical activity levels were
estimated as 1.6 in mid and late pregnancy. Applying this method, adequate dietary data was reported
in 85 (89%, EI:BMR 1.04–2.47) and 74 (84%, EI:BMR 1.04–2.47) women in mid and late pregnancy,
respectively. Removing the under/over-reporters had no material effect on the findings so they were
retained in the final analysis.
Neonatal anthropometry was obtained from electronic medical records. Birth length was
measured by experienced midwives in the delivery ward, at the time of birth as part of routine
clinical care, using a Seca measuring mat for infants. Crown to heel length was re-measured within
the first 48 h of birth by an endocrinologist (TPM) and one of the two research dietitians (RM, SB)
for Pea Pod measurement, using a neonatometer. Infant weight-for-age z-score was calculated using
gender-specific reference database from the World Health Organization (WHO Anthro for personal
computers software, version 3.2.2, Geneva, Switzerland) [27]. Ponderal index was calculated as birth
weight (g) divided by length (cm)3 ˆ 100. Neonatal body composition was assessed within 48 h
after birth, using an air-displacement plethysmograph device (PEA POD, COSMED, Concord, CA,
USA) [28]. Infant hair was smoothed down with water to minimize air behaving isothermally.
2.3. Statistics
Primary outcome was neonatal body composition, expressed as fat mass index (FMI; FM
(kg)/length (m)2) and fat-free mass index (FFMI; FFM (kg)/length (m)2). By adjusting for neonatal
length, FM and FFMI have been demonstrated to be the best proxy for infant body composition [29,30].
Normally distributed data are presented as means ˘ standard deviation (SD) and number (n) and
percentage (%) for frequency variables. Non-normally distributed data are presented as median, 25th
and 75th percentiles. Multiple linear regression analyses were used to assess the effect of maternal
macronutrient intake in mid and late pregnancy on infant body composition at birth, expressed as
FMI and FFMI. The analyses were adjusted for maternal pre-pregnancy BMI, GDM, gender and
gestational age (significance set at p < 0.05). Adjusted R2, beta-value and 95% confidence intervals (CI)
are reported. Statistical analyses were performed using SPSS Version 21 (IBM Australia, St Leonards,
NSW, Australia).
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The geometric framework [31] is a state-space nutritional modeling method used to explore
interactive effects of maternal macronutrient intake (expressed as percentage of total energy, %E) on
infant body composition. This approach allowed visualization of the complex relation between one
outcome variable (FMI or FFMI) and two macronutrients in the maternal diet, plotted on the x and y
axis. Infant body composition is represented by isolines, rising from dark blue (representing the lowest
values) to dark red (representing the highest values). The graphics were drawn using the R software
(R 3.0, the R Project Statistical Computing). Bland Altman was used to assess the agreement between
birth length and re-measured length for Pea Pod measurement.
3. Results
Of the 139 women enrolled in the GI Baby 3 study, 125 completed the protocol. Of these,
96 neonates (77%) had body composition assessment within 48 h after birth. The measurement
error between birth length and re-measured length was 0.78 mm, limits of agreement 48.7 to 51.7 mm
and intra-class correlation was 0.894, 95% CI 0.841 to 0.929, p < 0.001. Completed food records were
available for 96 and 88 mothers in mid and late pregnancy, respectively (Figure 1). Maternal and
neonatal characteristics are presented in Table 1.
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Figure 1. Flow of participants through the glycemic index (GI) Baby 3 Study.
Dietary data in mid and late pregnancy for women with neonatal body composition assessment
are presented in Table 2.
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Table 1. Maternal and neonatal characteristics (n = 125).
Characteristic Value
Age (year) 34.8 ˘ 4.3
Pre-pregnancy BMI (kg/m2) 25.2 ˘ 5.3
BMI ě 25 kg/m2 45 (36.0)
Ethnicity
Caucasian 72 (57.6)
Asian 33 (26.4)
Others 20 (16.0)
Tertiary education 95 (76.0)
Nulliparous 59 (47.2)
GWG (kg) 10.9 ˘ 5.5
IOM weight gain range
Below 44 (35.8)
Within 51 (41.5)
Above 28 (22.8)
Delivery
Vaginal delivery 89 (71.2)
Elective caesarean 18 (14.4)
Emergency caesarean 18 (14.4)
GDM 38 (30.4)
GDM diagnosed
<20 weeks gestation 20 (16)
26–28 weeks gestation 18 (14.4)
Insulin use 23 (18.4)
HbA1c (%) 1 4.9 (0.3)
ISI 2 9.9 (4.8)
Gestational age 3 39.6 (38.7, 40.4)
Male 39.2 (35, 42)
Female 39.8 (35.6, 41.5)
Sex (male) 60 (48)
Birth weight (kg) 3.4 ˘ 0.4
Male 3.4 ˘ 0.5
Female 3.5 ˘ 0.4
Birth length (cm) 3 50.0 (49, 51)
Male 50 (43.5, 55.0)
Female 50.5 (45.0, 57.0)
Weight-for-age z-score 0.2 ˘ 0.9
Male 0.0 ˘ 1.0
Female 0.4 ˘ 0.8
Ponderal Index (kg/m3) 2.7 ˘ 0.2
Male 2.7 ˘ 0.2
Female 2.7 ˘ 0.2
%FM 4 10.1 ˘ 3.8
Male 8.8 ˘ 3.3
Female 11.2 ˘ 3.9
FMI 3,4 1.3 (0.9, 1.6)
Male 1.2 ˘ 0.5
Female 1.5 ˘ 0.6
FFMI 4 11.6 ˘ 0.9
Male 11.8 ˘ 1.1
Female 11.5 ˘ 0.8
Mean ˘ SD (all such values); n (%) (all such values). 1 Data available in 123 subjects; 2 data available in 115
subjects; 3 median (25th, 75th percentiles) (all such values); 4 data available in 96 infants, 48 male and 52 female.
GWG, gestational weight gain; IOM, Institute of Medicine; GDM, gestational diabetes mellitus.
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Table 2. Maternal daily dietary intake in mid and late pregnancy of GI Baby 3 participants whose
infants had assessment of body composition within 48 h of birth.
Heading Mid Pregnancy Late Pregnancy
n 96 88
Energy (MJ) 8.8 ˘ 1.9 8.3 ˘ 1.6
Protein (g) 100.0 ˘ 23 97.0 ˘ 28.2
Total fat (g) 80.6 ˘ 22.8 77.5 ˘ 24.3
Total carbohydrates (g) 233.6 ˘ 64.3 210.3 ˘ 47.0
Sugars (g) 95.4 ˘ 36 89.0 ˘ 27.5
Starch (g) 136.6 ˘ 48 120.0 ˘ 31.3
Fiber (g) 25.8 ˘ 8.3 27.0 ˘ 8.6
P:C ratio 0.5 ˘ 0.2 0.5 ˘ 0.2
GI 57 ˘ 5 54 ˘ 6
GL 125 ˘ 41 106 ˘ 30
Protein (%E) 19.5 ˘ 4.1 20.0 ˘ 4.1
Total fat (%E) 33.6 ˘ 5.7 34.2 ˘ 6.0
Saturated fat (%E) 12.7 ˘ 3.0 12.3 ˘ 3.0
Carbohydrates (%E) 43.5 ˘ 6.5 42.1 ˘ 6.4
Mean ˘ SD (all such values). P:C ratio, protein-to-carbohydrate ratio; GI, glycemic index; GL, glycemic load;
%E, percentage of total energy.
Maternal Macronutrient Balance and Neonatal Body Composition
Multiple linear regression analyses of associations between maternal diet in mid pregnancy and
neonatal body composition are summarized in Table 3.
Table 3. Maternal daily dietary intake in mid pregnancy and offspring fat-free mass index (FFMI) and
fat mass index (FMI) (n = 96).
R2 Beta 95% CI p
FFMI
Energy (MJ) 0.063 0.035 ´0.071, ´0.141 0.517
Protein (%E) 0.059 ´0.003 ´0.050, 0.043 0.883
Total fat (%E) 0.123 0.041 0.009, 0.073 0.012
Saturated fat (%E) 0.126 0.079 0.019, 0.139 0.010
Carbohydrates (%E) 0.104 ´0.030 ´0.057, ´0.002 0.037
Fiber (%E) 0.069 ´0.144 ´0.443, 0.154 0.339
P:C ratio 0.067 0.471 ´0.569, 1.512 0.371
GI 0.064 ´0.012 ´0.046, 0.023 0.503
GL 0.070 ´0.002 ´0.007, 0.002 0.312
FMI
Energy (MJ) 0.073 0.046 ´0.017, 0.108 0.151
Protein (%E) 0.075 ´0.021 ´0.048, 0.007 0.134
Total fat (%E) 0.076 0.015 ´0.004, 0.034 0.131
Saturated fat (%E) 0.067 0.022 ´0.015, 0.059 0.235
Carbohydrates (%E) 0.055 ´0.004 ´0.021, 0.013 0.615
Fiber (%E) 0.059 0.074 ´0.104, 0.252 0.413
P:C ratio 0.056 ´0.205 ´0.826, 0.416 0.513
GI 0.052 0.002 ´0.019, 0.022 0.875
GL 0.054 0.001 ´0.002, 0.003 0.643
Multiple linear regression, adjusted for maternal pre-pregnancy BMI, GDM, gender and gestational age. %E,
percentage of total energy; P:C ratio, protein-to-carbohydrate ratio; GI, glycemic index; GL, glycemic load.
In mid pregnancy, only carbohydrate, total fat and saturated fat displayed significant relationships.
Carbohydrate energy (%E) was negatively correlated with offspring FFMI, explaining ~10% (p = 0.037)
of the variation. Conversely, total fat (%E) and saturated fat (%E) in mid pregnancy were both
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positively correlated with offspring FFMI, explaining ~12% (p = 0.012) and ~13% (p = 0.010) of the
variation, respectively.
Figure 2 illustrates these associations using ‘response surfaces’. Neonatal FFMI was greatest when
maternal dietary carbohydrate was <55%E and fat intakes were >30%E.
In contrast to FFMI, there were no significant associations between neonatal FMI and maternal
dietary intake in mid pregnancy. Similarly, there were no significant associations with protein intake
(%E), P:C ratio or dietary fiber in mid pregnancy with neonatal FMI or FFMI.
Table 4 summarizes the findings in late pregnancy after women had received nutrition education
for at least 16–20 weeks. This included dietary GI advice (either low or moderate GI depending on
treatment group) and instruction to follow a healthy diet.
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Figure 2. Effects of maternal carbohydrate (%E) and total fat (%E) intake in mid pregnancy and
offspring FFMI. The isolines for the FFMI rise in elevation from dark blue to dark red. Neonatal FFMI
was greatest at low proportions of dietary carbohydrate (<55%E) and moderate fat (>30%E) intakes
(n = 96).
Maternal macronutrient balance in late pregnancy was associated with differences in both neonatal
FMI and FFMI. Higher carbohydrate intake (%E) was associated with lower FMI, explaining ~12% of
the variance (p = 0.034), while higher intakes of total fat (%E) and saturated fat (%E) predicted higher
FMI, explaining ~12% of the variation (p = 0.032 and p = 0.033 respectively). Thus, offspring FMI was
greatest at relatively low intake of carbohydrate (<45%E) and relatively high intake of fat (>40%E,
Figure 3).Nutrients 2016, 8, 270  8 of 13 
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11% of the variation in FFMI (p = 0.010). 
There were  no  significant  associations  between maternal  protein  intake  (%E),  P:C  ratio  or 
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Figure 3. Effects of maternal carbohydrate (%E) and total fat intake (%E) in late pregnancy and neonatal
FMI. The isolines for the FMI rise in elevation from dark blue to dark red. Offspring FMI was greatest
at high maternal intake of total fat (>40%E) and moderate intake of carbohydrate (<45%E) (n = 88).
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Table 4. Maternal daily dietary intake in late pregnancy and offspring FFMI and FMI (n = 88).
R2 Beta 95% CI p
FFMI
Energy (MJ) 0.037 0.020 ´0.106, 0.147 0.750
Protein (%E) 0.038 ´0.011 ´0.063, 0.041 0.681
Total fat (%E) 0.045 0.015 ´0.018, 0.049 0.369
Saturated fat (%E) 0.040 0.020 ´0.045, 0.084 0.544
Carbohydrates (%E) 0.047 ´0.017 ´0.051, 0.017 0.330
Fiber (%E) 0.040 0.072 ´0.175, 0.319 0.564
P:C ratio 0.036 0.126 ´1.098, 1.349 0.839
GI 0.110 ´0.040 ´0.071, ´0.010 0.010
GL 0.064 ´0.006 ´0.013, 0.001 0.118
FMI
Energy (MJ) 0.079 0.026 ´0.049, 0.100 0.495
Protein (%E) 0.073 ´0.003 ´0.034, 0.027 0.835
Total fat (%E) 0.124 0.021 0.002, 0.040 0.032
Saturated fat (%E) 0.124 0.040 0.003, 0.077 0.033
Carbohydrates (%E) 0.123 ´0.021 ´0.042, ´0.002 0.034
Fiber (%E) 0.084 0.070 ´0.074, 0.214 0.336
P:C ratio 0.090 0.437 ´0.272, 1.147 0.224
GI 0.073 0.001 ´0.018, 0.020 0.927
GL 0.084 ´0.002 ´0.006, 0.002 0.322
Multiple linear regression, adjusted for maternal pre-pregnancy BMI, GDM, gender and gestational age. %E,
percentage of total energy. P:C ratio, protein-to-carbohydrate ratio. GI, glycemic index. GL, glycemic load.
In addition, in late pregnancy, high proportions of carbohydrate (>50%E), particularly from high
GI sources, predicted lower neonatal FFMI as illustrated in Figure 4. Dietary GI alone explained 11%
of the variation in FFMI (p = 0.010).
There were no significant associations between maternal protein intake (%E), P:C ratio or dietary
fiber in late pregnancy with either FMI or FFMI.Nutrients 2016, 8, 270  9 of 13 
 
 
Figure  4.  Effects  of  maternal  carbohydrate  intake  (%E)  and  dietary  GI  in  late  pregnancy  and 
offspring FFMI. The  isolines  for  the FMI  rise  in  elevation  from dark blue  to dark  red. FFMI was 
lowest at high proportions of carbohydrate intake (>50%E) derived from high GI sources (>50 GI) (n = 
88). 
4. Discussion 
In  this  study, we  explored  a  large database  containing data on maternal dietary  intake and 
infant body composition assessed by air displacement plethysmography within 48 h of birth. We 
hypothesised  that  the  overall  quantity  and  quality  of  macronutrients  in  the  maternal  diet, 
particularly  of  carbohydrate,  could  have  trimester‐specific  effects  on  neonatal  growth  and  body 
composition. Our  findings  suggest  that diet  composition per se may  indeed  influence  fetal  tissue 
growth and that the effects may differ from early to late pregnancy. In mid pregnancy, we found that 
a higher carbohydrate diet containing less total and/or saturated fat as a proportion of total dietary 
energy was  associated with  lower  indices  of  neonatal  fat‐free mass, while.  Thus,  depending  on 
pregnancy  stage, a high  carbohydrate‐low  fat diet, particularly  from high glycemic  sources, may 
reduce neonatal indices of both lean mass and adiposity. 
To explain these findings, we speculate that the circulating fuels in the mother’s bloodstream 
(glucose, free fatty acids, amino acids and possibly ketones) will influence the fetal tissue responses 
and  therefore  tissue  growth.  Higher  blood  glucose  levels  in  the  mother,  will  stimulate 
hyperinsulinaemia  in  the  fetus  and  thereby  stimulate  the  growth  of  lean  or  adipose  tissue, 
depending on the stage of pregnancy [32]. In human infants, the majority of adipose tissue is laid 
down  in  the  3rd  trimester.  It  is  likely  that high  levels of  free  fatty  acids  (the building blocks of 
triglycerides) in the mother’s blood stream will encourage adipose tissue growth but not lean tissue 
[33]. Maternal  intake of  saturated  fatty acids, but not monounsaturated or polyunsaturated  fatty 
acids, has been associated with greater fetal adiposity, but the mechanisms remain unclear [18]. 
Our  results  suggest  that  the  quantity  and  quality  of maternal macronutrient  intake  during 
pregnancy may  be more  important  contributors  to  fetal  growth  and  body  composition  than  is 
currently recognised. Although cross‐sectional studies cannot prove cause‐and‐effect, these findings 
in a group of women at risk of GDM have important implications. Low fat mass at birth is directly 
related  to higher morbidity  in  the  first weeks of  life [34] and may also be  linked  to higher risk of 
cardiovascular disease  in  later  life  [35]. At  the  other  extreme,  excessive  body  fat  in  the  neonate 
(macrosomia) is associated with adverse pregnancy outcomes and increased susceptibility to obesity 
and metabolic disease in adult life [36]. 
Although there are few previous studies of similar nature, their findings are consistent in part 
with  ours.  Blumfield  et  al.  reported  greater  fetal  adiposity  at  the midthigh  associated with  low 
carbohydrate (<40%E) intake and high fat (>40%E) in a large group of Australian mother‐infant pairs 
Figure 4. Effects of maternal carbohydrate intake (%E) and dietary GI in late pregnancy and offspring
FFMI. The isolines for the FMI rise in elevation from dark blue to dark red. FFMI was lowest at high
proportions of carbohydrate intake (>50%E) derived from high GI sources (>50 GI) (n = 88).
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4. Discussion
In this study, we explored a large database containing data on maternal dietary intake and
infant body composition assessed by air displacement plethysmography within 48 h of birth.
We hypothesised that the overall quantity and quality of macronutrients in the maternal diet,
particularly of carbohydrate, could have trimester-specific effects on neonatal growth and body
composition. Our findings suggest that diet composition per se may indeed influence fetal tissue
growth and that the effects may differ from early to late pregnancy. In mid pregnancy, we found
that a higher carbohydrate diet containing less total and/or saturated fat as a proportion of total
dietary energy was associated with lower indices of neonatal fat-free mass, while. Thus, depending
on pregnancy stage, a high carbohydrate-low fat diet, particularly from high glycemic sources, may
reduce neonatal indices of both lean mass and adiposity.
To explain these findings, we speculate that the circulating fuels in the mother’s bloodstream
(glucose, free fatty acids, amino acids and possibly ketones) will influence the fetal tissue responses and
therefore tissue growth. Higher blood glucose levels in the mother, will stimulate hyperinsulinaemia
in the fetus and thereby stimulate the growth of lean or adipose tissue, depending on the stage of
pregnancy [32]. In human infants, the majority of adipose tissue is laid down in the 3rd trimester. It is
likely that high levels of free fatty acids (the building blocks of triglycerides) in the mother’s blood
stream will encourage adipose tissue growth but not lean tissue [33]. Maternal intake of saturated fatty
acids, but not monounsaturated or polyunsaturated fatty acids, has been associated with greater fetal
adiposity, but the mechanisms remain unclear [18].
Our results suggest that the quantity and quality of maternal macronutrient intake during
pregnancy may be more important contributors to fetal growth and body composition than is currently
recognised. Although cross-sectional studies cannot prove cause-and-effect, these findings in a group
of women at risk of GDM have important implications. Low fat mass at birth is directly related to
higher morbidity in the first weeks of life [34] and may also be linked to higher risk of cardiovascular
disease in later life [35]. At the other extreme, excessive body fat in the neonate (macrosomia) is
associated with adverse pregnancy outcomes and increased susceptibility to obesity and metabolic
disease in adult life [36].
Although there are few previous studies of similar nature, their findings are consistent in part with
ours. Blumfield et al. reported greater fetal adiposity at the midthigh associated with low carbohydrate
(<40%E) intake and high fat (>40%E) in a large group of Australian mother-infant pairs who had
ultrasound measurements of abdominal and thigh circumference at 36 weeks gestation [18]. In a
secondary analysis of the ROLO study (randomised control trial of low glycaemic index diet versus
no dietary intervention to prevent recurrence of fetal macrosomia), neonatal abdominal adiposity
was positively associated with maternal saturated fat intake [37]. In a British cohort, lower maternal
carbohydrate intake during pregnancy was associated with greater child adiposity at 9 years of age [19].
Finally, animal models also indicate that a high-fat diet during gestation will produce offspring that
develop increased adiposity or reduced lean mass, independent of maternal obesity [38].
In the present study, we found trimester specific effects of dietary carbohydrate. In mid pregnancy,
carbohydrate energy appeared to influence only FFMI, while in late pregnancy it predicted only
FMI. Furthermore, in late pregnancy but not mid pregnancy, higher dietary GI was associated with
lower FFMI. Indeed, the GI alone explained a similar amount of the variation (11%) in lean mass
as carbohydrate. This implies that higher intake of carbohydrate foods with a high GI, such as
bread, rice and potatoes, might act to reduce fetal lean mass accumulation. Because lean mass is a
primary determinant of basal metabolic rate, the combined effects of a high carbohydrate, high GI diet
throughout pregnancy may increase offspring predisposition to weight gain in later life.
Unlike previous studies, we did not find a relationship between maternal protein intake and the
growth and body composition of her fetus. This may have resulted from the relatively high (~20%E)
and narrow range of protein intake in our participants. Furthermore, unlike previous studies, we did
not find a relationship between the maternal protein to carbohydrate (P:C) ratio and body composition.
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Blumfield et al. reported that a higher ratio (more protein and less carbohydrate) was associated
with lower fetal abdominal fat mass assessed by fetal ultrasound measurements at ~36 weeks [18].
Our sample of mothers, however, had a very high ratio (P:C ratio = 1:2) that may have reduced the
ability to detect a significant relationship. It should also be acknowledged that the effects of maternal
diet on fetal body composition may differ between pregnancies from general population (such as in
the WATCH cohort [18]) and pregnancies at high risk of developing GDM.
Total energy intake during pregnancy also plays a role in influencing fetal growth and birth
weight [2]. However, we did not find a significant association between maternal energy intake and
offspring body composition. Energy intake in our sample was lower than the results reported in
a recent review on energy and macronutrient intakes during pregnancy [39]. Indeed, mean energy
intakes during pregnancy pooled from 7 different studies conducted in Australia was ~9260 ˘ 1100 kJ
while our sample reported a mean energy intake of 8570 ˘ 1440 kJ. Furthermore, our mothers sample
reported a decrease in energy intake with advancing pregnancy [39]. These observations may be
related to the fact that all of our participants had risk factors for the development of GDM (including
high pre-pregnancy BMI, family history or previous macrosomic infant) and were therefore cautioned
to avoid excessive weight gain.
The relative strengths and weaknesses of our study should be noted. We benefited from a large
dataset of women whose dietary intake had been recorded using 3-day records at specific stages
of pregnancy. Trained dietitians checked and analysed the data. Neonatal body composition was
assessed within 48 h of birth by air-displacement plethysmography, a method validated against
the 4-compartments model [28] and deuterium dilution [40]. Primary outcomes were expressed as
FMI and FFMI, which adjust tissue masses for body length while keeping FM and FFM outcomes
separate. These indices are recognized as the most appropriate approach to evaluating pediatric
body composition [29,30]. Using %FM as an index of fatness has been suggested to be misleading
as it ignores between-subject variation in FFM. For example, infants will differ in %FM if they have
identical FFM but different FM or if they have identical FM but different FFM [29]. Finally, we used the
geometric framework to capture multidimensional aspects of nutrition. This novel approach reveals
interactions that may not be evident when macronutrients are examined in two-dimensional space.
The limitations of our study must also be acknowledged. Under-reporting is an important
concern, especially among overweight and obese women. Mean energy intake was 8.8 and 8.3 MJ in
mid and late pregnancy respectively, which is lower than that reported by others [41,42]. Dietary data
collected over 3-days for the purposes of a study may not be a reliable representation of actual food
intake over the whole trimester. Moreover, it is possible that variation between individuals is actually
variation from day-to-day (intra-individual variation) and variability may be higher for some nutrients
versus others. Our participants were at risk of developing GDM and received intensive nutrition
education to improve the quality of their diet which means our findings may not be generalized to the
normal population of pregnant women. The majority of the participants in the GI Baby 3 study had a
tertiary education and their food intake, particularly the relatively high proportion of protein, may not
be representative.
FMI and FFMI are suggested to be the best proxy for body composition assessment, providing
reliability and accuracy in body length measurement. However, neonatal crown to heel length is not
easy to measure precisely and a lack of accuracy may cause distortion to the final result of the equation.
Findings relying on these indices should be interpreted with caution. Maternal metabolic state will
also influence neonatal body composition and potentially override the effects of maternal diet. Indeed,
insulin resistance in the first half of pregnancy, and glycemia in the second half of pregnancy have
been shown to be highly predictive of newborn adiposity [43]. Finally, our statistical analysis is prone
to type 1 error because multiple relationships have been tested. Causality cannot be inferred from this
study due to its observational nature and the possibility of residual confounding.
Nutrients 2016, 8, 270 11 of 13
5. Conclusions
A better understanding of the effects of maternal nutrition in early life and its influence on
short- and long-term health should be a priority area of study in nutrition research. This analysis
raises questions and hypotheses for further study. In women at high risk of diabetes, neonatal body
composition may be partially driven by maternal dietary balance. Depending on pregnancy stage,
a high carbohydrate-low fat diet, particularly from high glycemic sources, may reduce neonatal indices
of both adiposity and lean mass. At one extreme, a very high carbohydrate diet may compromise the
ability to optimise fetal body composition with adequate lean tissue and adipose tissue stores for life
outside the womb. At the other extreme, a very low carbohydrate diet with higher fat/saturated fat
content may predispose the infant to macrosomia with corresponding adverse effects on pregnancy
outcomes and later risk of obesity.
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